111 Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

111 hat ein Gesamteigenkapital von CN¥279.4M und eine Gesamtverschuldung von CN¥207.0M, was einen Verschuldungsgrad von 74.1% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen CN¥2.9B bzw. CN¥2.6B.

Wichtige Informationen

76.7%

Verhältnis von Schulden zu Eigenkapital

CN¥189.37m

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	CN¥595.45m
Eigenkapital	CN¥246.73m
Gesamtverbindlichkeiten	CN¥2.54b
Gesamtvermögen	CN¥2.79b

Jüngste Berichte zur Finanzlage

Recent updates

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

Sep 10

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

Aug 25

111, Inc.'s Inexorable Drive Towards Profitability

Jul 27

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

Sep 16

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

Aug 25

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

Aug 18

Is 111 (NASDAQ:YI) A Risky Investment?

Apr 09

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

Mar 05

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

Jan 29

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Dec 25

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Dec 04

111 reports Q3 results, provides Q4 revenue guidance

Nov 19

111, Inc.: Cheap But Risky And Controlled By Founders

Nov 16

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: YIDie kurzfristigen Aktiva des Unternehmens (CN¥2.8B) übersteigen seine kurzfristigen Passiva (CN¥2.6B).

Langfristige Verbindlichkeiten: YIDie kurzfristigen Vermögenswerte des Unternehmens (CN¥2.8B) übersteigen seine langfristigen Verbindlichkeiten (CN¥60.8M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: YI über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: YIDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 1.8% auf 74.1% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: Obwohl YI unrentabel ist, verfügt es über eine ausreichende Cash-Runway für mehr als 3 Jahre, wenn es seinen derzeitigen positiven freier Cashflow beibehält.

Vorhersage Cash Runway: YI ist unrentabel, verfügt aber über eine ausreichende Liquiditätsreserve für mehr als drei Jahre, da der freie Cashflow positiv ist und um 6.7% pro Jahr wächst.

111 Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. announced delayed 20-F filing

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

Is 111 (NASDAQ:YI) A Risky Investment?

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Recent updates

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

111, Inc. to Report Q2, 2024 Results on Aug 29, 2024

111, Inc. announced delayed 20-F filing

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Second quarter 2023 earnings released: CN¥0.68 loss per share (vs CN¥1.14 loss in 2Q 2022)

111, Inc. to Report Q2, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: CN¥0.38 loss per share (vs CN¥1.33 loss in 1Q 2022)

111, Inc. to Report Q1, 2023 Results on Jun 15, 2023

Full year 2022 earnings released: CN¥5.00 loss per share (vs CN¥8.08 loss in FY 2021)

Third quarter 2022 earnings released: CN¥1.16 loss per share (vs CN¥3.05 loss in 3Q 2021)

Insufficient new directors

111, Inc. to Report Q3, 2022 Results on Dec 01, 2022

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Second quarter 2022 earnings released

111, Inc. Provides Revenue Guidance

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

111, Inc. to Report Q2, 2022 Results on Aug 25, 2022

111, Inc.'s Inexorable Drive Towards Profitability

First quarter 2022 earnings released

Insufficient new directors

111, Inc. to Report Q1, 2022 Results on Jun 16, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

111, Inc. to Report Q4, 2021 Results on Mar 17, 2022

Third quarter 2021 earnings released

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2021 earnings released

111, Inc. Provides Preliminary Revenue Guidance for the Third Quarter of 2021

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

First quarter 2021 earnings released: CN¥1.77 loss per share (vs CN¥1.52 loss in 1Q 2020)

111, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

Is 111 (NASDAQ:YI) A Risky Investment?

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

111, Inc. Provides Earnings Guidance for the First Quarter of 2021

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

111, Inc. to Report Q4, 2020 Results on Mar 18, 2021

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

New 90-day high: US$12.70

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

New 90-day high: US$7.62

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Third quarter 2020 earnings released: CN¥1.32 loss per share

111 reports Q3 results, provides Q4 revenue guidance

111, Inc.: Cheap But Risky And Controlled By Founders

New 90-day high: US$7.45

111, Inc. Announces Management Changes

111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

New 90-day low - US$5.96

First half earnings released

111, Inc. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day low - US$6.14

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen